Ontvang nu dagelijks onze kooptips!

word abonnee
IEX 25 jaar desktop iconMarkt Monitor

Aandeel Galapagos AEX:GLPG.NL, BE0003818359

Laatste koers (eur) Verschil Volume
26,240   -0,220   (-0,83%) Dagrange 26,200 - 26,780 23.406   Gem. (3M) 96,8K

KOERS GALAPAGOS 2015

16.480 Posts
Pagina: «« 1 ... 294 295 296 297 298 ... 824 »» | Laatste | Omlaag ↓
  1. Loureiro 7 mei 2015 21:11
    quote:

    risky N schreef op 7 mei 2015 20:58:

    www.retailroadshow.com/sys/launch.asp...

    Weet niet of het al eerder hier is gepost.

    This offering is expected to price on or about the Week of May 11, 2015.
    Voor zover ik weet nog niet gepost of slechts gedeeltelijk. Thx.
    Ik heb de indruk dat naar gelang de roadshow vordert en hoe groter de belangstelling, de koers verder zal stijgen : instapprijs zal bijgevolg in de buurt van 38 à 40 euro liggen.
  2. [verwijderd] 7 mei 2015 21:21
    quote:

    Sal schreef op 7 mei 2015 17:32:

    B..K ik meende dat jij dacht dat we eind van d week onder de 30 euro zouden staan??
    Ach je weet dat er bij verschillende inzichten altijd maar één partij de winnaar is. En dan haalt de winnende partij altijd z'n gelijk

    Niets menselijks is de belegger vreemd :-)
  3. [verwijderd] 7 mei 2015 21:32
    quote:

    risky N schreef op 7 mei 2015 20:58:

    www.retailroadshow.com/sys/launch.asp...

    Weet niet of het al eerder hier is gepost.

    This offering is expected to price on or about the Week of May 11, 2015.
    Dank hiervoor,

    Aan een ieder, er zit een presentatie bij die je moet zien! Erg interessant. Dus in plaats van IPO koersschatting te posten even kijken en luisteren naar Onno en consorten.
  4. Ol' DB 7 mei 2015 21:45
    quote:

    stappa schreef op 7 mei 2015 21:32:

    [...]

    Dank hiervoor,

    Aan een ieder, er zit een presentatie bij die je moet zien! Erg interessant. Dus in plaats van IPO koersschatting te posten even kijken en luisteren naar Onno en consorten.

    Yes, I recommend that too :-)
    I guess they must be quite convinced of the 24-week results.
    Really don't think they are going to Nasdaq for the share price to crash a couple of weeks later after bad results.
  5. [verwijderd] 7 mei 2015 21:48
    quote:

    Ol' DB schreef op 7 mei 2015 21:45:

    [...]

    Yes, I recommend that too :-)
    I guess they must be quite convinced of the 24-week results.
    Really don't think they are going to Nasdaq for the share price to crash a couple of weeks later after bad results.
    Or, they know they will suck, and try to cash now as they know later will be too late.

    Not mine maining, but it could so mare happen!
  6. [verwijderd] 7 mei 2015 21:49
    quote:

    SJURVM schreef op 7 mei 2015 21:16:

    [...]

    very good to see this
    Iy also confirms that gong to Nasdaq is to have a correct valuation of the company

    Obviously the team believes that Galapagos is not valued at a proper price considering what they have with 0634 and the other drugs in the pipeline.

  7. [verwijderd] 7 mei 2015 21:53
    quote:

    SJURVM schreef op 7 mei 2015 21:49:

    [...]

    Iy also confirms that gong to Nasdaq is to have a correct valuation of the company

    Obviously the team believes that Galapagos is not valued at a proper price considering what they have with 0634 and the other drugs in the pipeline.


    dat werd verbaal en non verbaal wel duidelijk
  8. Hunter300 7 mei 2015 21:54
    quote:

    ilhabite schreef op 7 mei 2015 21:00:

    Mr Chicken Little € 35.00 of $39.75
    Mr Greenspan € 35,50
    mr. gala € 36,00
    bulebijter € 36,85
    sal € 37,50
    mickjagger2 € 37.75
    TheBateman. € 38,00
    Deechte € 38,00
    Tuinman € 38,00
    Roan3009 € 38,25
    mr.franz € 38,50
    Erco € 38,50
    Hobey € 39,10
    Pocketjannen € 39,25
    B...K € 39,50
    grand sasso € 39,75
    j. leek € 40,00
    MtBaker € 40,00
    Ruud Rubbers: € 40,50
    ilhabite € 40,50
    Maycon: € 41,00
    grrrrrrrrrrrr pffffff zucht: € 41,50
    Newbe: € 41,67
    Allebeginismoeilijk: €42
    Vlekos: € 42,50
    Egeltjemetstekel $42,43 USdollar (bij eurokoers van 1,127095 =dat:) €37,65 euro
    Saralee 44,5 usd.
    CallHans revisted $50
    Staycalm € 50,00 -
    Hunter300 US Dollar 45

    See more at: www.beursonline.nl/Forum/Topic/132065...
  9. [verwijderd] 7 mei 2015 21:55
    quote:

    SJURVM schreef op 7 mei 2015 21:49:

    [...]

    Iy also confirms that gong to Nasdaq is to have a correct valuation of the company

    Obviously the team believes that Galapagos is not valued at a proper price considering what they have with 0634 and the other drugs in the pipeline.


    I don't want to be an negative a-hole all the time, but really? Show me a management team that thinks the company is valued correctly? And what is the difference between telling the major players their story and have them buy in Europe vs gIPO in US? It is promotion, and collection of money. Nothing wrong with that, but nothing more either (imho).

    (PS I don't mind being an occasional a-hole ;) )
  10. Ol' DB 7 mei 2015 22:03
    quote:

    chicken little schreef op 7 mei 2015 21:57:

    [...]
    only if thy knew what the results were, and they don't. So, my point is a moot as yours, as both are based on non-information.
    I had deleted that post right after posting because I knew it would just spark another response of you.
    Too late, good night.
  11. [verwijderd] 7 mei 2015 22:11
    quote:

    chicken little schreef op 7 mei 2015 21:55:

    [...]

    I don't want to be an negative a-hole all the time, but really? Show me a management team that thinks the company is valued correctly? And what is the difference between telling the major players their story and have them buy in Europe vs gIPO in US? It is promotion, and collection of money. Nothing wrong with that, but nothing more either (imho).

    (PS I don't mind being an occasional a-hole ;) )
    Not at all. Every opinion is valued for what it is.

    But you can sense the frustration of the finance guy when he said the reason for the issue. (emotion should not be part of investing I know)

    Indeed every CEO would say that his company is undervalued. Particulaly if he has options as part of his pay packet :)

    What they are saying is that in the US there is a better understanding in investing in a biotech company. More of a long term approach if you like.
    Which means that they would prefer US long term institutional investors as shareholders. In addition to the Europe ones no doubt.
    Also there is a larger pool of investors in the US willing to invest in Biotech than in Europe.
    I do not have the figures but how many Biotech funds are there in Europe v USA?

16.480 Posts
Pagina: «« 1 ... 294 295 296 297 298 ... 824 »» | Laatste |Omhoog ↑

Meedoen aan de discussie?

Word nu gratis lid of log in met je emailadres en wachtwoord.